CPRX Q3 Earnings & Revenues Beat Estimates, '24 View Raised, Stock Up
Catalyst stock gains on strong third-quarter results, beating earnings and revenue estimates, primarily driven by Firdapse sales. Management raises sales guidance.
| Ticker |
Sentiment |
Impact |
|
ALLO
|
Neutral
|
18 %
|
|
CPRX
|
Neutral
|
27 %
|
|
ESALF
|
Neutral
|
5 %
|
|
BIIB
|
Neutral
|
9 %
|
